Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Muscle”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03573765
What this trial is testing

Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data

Who this might be right for
OsteoarthritisDislocationsInflammatory Arthritis+14 more
University of Oxford 8,308,821
Early research (Phase 1)Ended earlyNCT04099277
What this trial is testing

LY3435151 in Participants With Solid Tumors

Who this might be right for
Solid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more
Eli Lilly and Company 2
Not applicableStudy completedNCT05934695
What this trial is testing

Lymphedema Severity on Shoulder Joint Function and Muscle Activation Patterns in Breast Cancer Survivors

Who this might be right for
Breast CancerBreast Cancer Female
Ahram Canadian University 75
Testing effectiveness (Phase 2)Study completedNCT03213665
What this trial is testing

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more
National Cancer Institute (NCI) 20
Not applicableActive Not RecruitingNCT06614699
What this trial is testing

Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Colorectal Cancer Patients

Who this might be right for
Colorectal CancerSarcopeniaObesity and Overweight
First Affiliated Hospital of Chongqing Medical University 8,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189793
What this trial is testing

Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of Bladder+1 more
First Affiliated Hospital of Wenzhou Medical University 106
Large-scale testing (Phase 3)Ended earlyNCT04688931
What this trial is testing

UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 282
Not applicableNot Yet RecruitingNCT07781956
What this trial is testing

Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Nanjing First Hospital, Nanjing Medical University 40
Not applicableUnknownNCT04702399
What this trial is testing

Hyaluronic Acid for the Prevention of Endocavitary Synechiae After Myomectomy

Who this might be right for
Patients With an Indication for Myomectomy or Polymyomectomy
Assistance Publique - Hôpitaux de Paris 76
Testing effectiveness (Phase 2)WithdrawnNCT07414992
What this trial is testing

Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

Who this might be right for
Bladder Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center
Very early researchStudy completedNCT02753309
What this trial is testing

Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
The University of Texas Health Science Center at San Antonio 33
Testing effectiveness (Phase 2)Study completedNCT01532687
What this trial is testing

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+16 more
OHSU Knight Cancer Institute 54
Post-approval studies (Phase 4)Looking for participantsNCT06734598
What this trial is testing

Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with Trismus After Radiotherapy

Who this might be right for
TrismusHead and Neck CancerRadiation Therapy Recipient+1 more
National Taiwan University Hospital 120
Testing effectiveness (Phase 2)Study completedNCT02307487
What this trial is testing

Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients

Who this might be right for
Bladder CancerNeoplasmsUrinary Bladder Diseases+1 more
UroGen Pharma Ltd. 14
Not applicableUnknownNCT06251570
What this trial is testing

Evaluation of Dual Task Performance and Respiratory Muscle Endurance in Patients With Lung Cancer

Who this might be right for
Lung Cancer
Hacettepe University 60
Post-approval studies (Phase 4)Study completedNCT02214602
What this trial is testing

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
Mansoura University 240
Large-scale testing (Phase 3)Looking for participantsNCT07480356
What this trial is testing

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNon-Muscle Invasive Bladder CarcinomaNon-muscle Invasive Bladder Cancer With Carcinoma in Situ
Protara Therapeutics 284
Not applicableStudy completedNCT04053101
What this trial is testing

Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
Institut Bergonié 130
Early research (Phase 1)Active Not RecruitingNCT05103631
What this trial is testing

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

Who this might be right for
Liver Cell CarcinomaSolid TumorWilms Tumor+5 more
Baylor College of Medicine 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05704244
What this trial is testing

Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder Cancer
Ferring Pharmaceuticals 25
Next Page